NCT05054725 Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies Status COMPLETED Phase PHASE2
NCT05053607 Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab Status RECRUITING Phase NA
NCT05049122 Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52) Status COMPLETED Phase PHASE4
NCT05042440 Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A Status COMPLETED Phase PHASE1
NCT05039840 Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05018806 Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT05017142 Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) Status RECRUITING Phase N/A
NCT05013554 Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors Status TERMINATED Phase PHASE1
NCT05002933 A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period Status COMPLETED Phase PHASE4
NCT05002777 Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04998604 EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients Status COMPLETED Phase PHASE4
NCT04982991 Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male Participants Status COMPLETED Phase PHASE1
NCT04980027 Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs Status COMPLETED Phase PHASE4
NCT04959448 Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04943302 Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis Status WITHDRAWN Phase PHASE2
NCT04940026 Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women Status COMPLETED Phase PHASE1
NCT04914897 A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) Status TERMINATED Phase PHASE2